Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients
Friday, 7 August 2020 ()
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. |
|
|||